| [1] |
Verdecchia A, Corazziari I, Gatta G, et al. Explaining gastric cancer survival differences among European countries[J]. Int J Cancer, 20 04, 109(5): 737-41.
|
| [2] |
Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease[J]. Cell, 2009, 139(5): 87 1-90.
|
| [3] |
Rosivatz E, Becker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer[J]. Am J Pathol, 2002, 161(5): 1881-91.
|
| [4] |
Yan W, Cao QJ, Arenas RB, et al. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition[J]. J Biol CHem, 2010, 285(18): 14042-51.
|
| [5] |
Wilmanns C, Steinhauer S, Grossmann J, et al. Site-dependent differences in clinical,pathohistolo-gical,and molecular parameters in metastastatic colon cancer[J]. Int J Biol Sci, 2009, 5(5): 458-65.
|
| [6] |
Davis R, Rizwani W, Banerjee S, et al. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer[J]. PLoS One, 2009, 4(10): e7524.
|
| [7] |
Kurashige J, Kamohara H, Watanabe M, et al. MicroRNA-200b reguletes cell proliferation,invision, and migration by directly targeting ZEB2 in gastric carcinoma[J]. Ann Surg Oncol, 2012, Suppl 3: S656-64.
|
| [8] |
Meng Z, Fu X, Chen X, et al. miR-194 is a maker of hepatic epithelial cell and suppresses metastasis of liver cancer cells in mice[J]. Hepatology, 2010, 52(6): 2148-57.
|
| [9] |
Zhou W, Li X, Liu F, et al. MiR-135a promotes growth and invasion in colorectal cancer via metastasis suppressor 1 in vitro[J]. Acta Biochim Biophys Sin(Shanghai), 2012, 44(10): 83 8-46.
|
| [10] |
Adam L, Zhong M, Choi W, et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy[J]. Clin Cancer Res, 2009, 15(16): 5060-72.
|
| [11] |
Chua HL, Bhat-Nakshatri P, Clare SE, et al. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2[J]. Oncogene, 2007, 26(5): 711-24.
|
| [12] |
Thiery JP. Epithelial-mesenchymal transitions in tumour progression[J]. Nat Rev Cancer, 2002, 2(6): 442-54.
|
| [13] |
Du C, Zhang C, Hassan S, et al. Protein kinase D1 suppressesepithelial-to-mesenchymal transition through phosphorylation of Snail[J]. Cancer Res , 2010, 70(20): 7810-9.
|
| [14] |
Shioiri M, Shida T, Koda K, et al. Slug expression is an independent prognostic parameter for poor survival in colorectal cancer patients[J]. Br J Cancer, 2006, 94(12): 1816-22.
|
| [15] |
Castro Alves C, Rosivatz E, Schott C, et al. Slug is overexpressed in gastric cancers and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin[J]. J Pathol, 2007, 211(5): 50 7-15.
|
| [16] |
Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis[J]. Dev Cell, 20 08, 14(6): 818-29.
|
| [17] |
Lee JM, Dedhar S, Kalluri R, et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease[J]. J Cell Biol, 2006, 172(7): 973-81.
|
| [18] |
Smith AL, Iwanaga R, Drasin DJ, et al. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer[J]. Oncogene, 2012, 31(50): 5162-71.
|
| [19] |
Chiou GY, Cherng JY, Hsu HS, et al. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelialmesenchymal transdifferentiation and cancer stem-like properties and in lung Aden carcinoma[J]. J Control Release, 2012, 159(2): 24 0-50.
|
| [20] |
Turcatel G, Rubin N, El-Hashash A, et al. mir-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells[J]. PLoS One, 2012, 7(1): e31032.
|
| [21] |
Schliekelman MJ, Gibbons DL, Faca VM, et al.Targets of the tumor suppressor miR-200 in regulation of the epithelialmesenchymal transition in cancer[J]. Cancer Res, 2011, 71(24): 76 70-82.
|
| [22] |
Tellez CS, Juri DE, Do K, et al. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells[J]. Cancer Res, 2011, 71(8): 3087-97.
|
| [23] |
Paterson EL, Kazenwadel J, Bert AG, et al. Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression[J]. Neoplasia, 2013, 15(2): 180-91.
|
| [24] |
Gregory PA, Bracken CP, Smith E, et al. An autocrine TGFbeta/ ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition[J]. Mol Biol Cell, 2011, 22(10): 1686-98.
|
| [25] |
Ahmad A, Aboukameel A, Kong D, et al. Phosphoglucose isomerase/autocrine motility factor mediates epithelialme s e n c h yma l t r a n s i t i o n r e g u l a t e d b y miR- 2 0 0 i n breast cancer cells[J]. Cancer Res, 2011, 71(9): 3400-9.
|
| [26] |
Jang BI, Li Y, Graham DY, et al. The role of CD44 in the pathogenesis, diagnosis, and therapy of gastric cancer[J]. Gut Liver, 2011, 5(4): 397-405.
|
| [27] |
Cai C, Yu JW, Wu JG, et al. Transforming growth factor-β1 generates epithelial-to-mesenchymal transition and promote CD44 expression in SGC7901 cells[J]. Guo Ji Wai Ke Xue Za Zhi, 2012, 39 (11): 746-51, cover3-4. [蔡成, 俞继卫, 吴巨钢, 等. TGF-β1诱 导胃癌细胞上皮间质转化及其上调CD44表达的实验研究[J]. 国际外科学杂志 , 2012, 39(11): 746-51, 封3-4.]
|
下载:
